{{Rsnum
|rsid=441810
|Gene=FAM3B
|Chromosome=21
|position=41326980
|Orientation=plus
|GMAF=0.3388
|Gene_s=FAM3B
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 64.6 | 31.9 | 3.5
| HCB | 61.3 | 38.0 | 0.7
| JPT | 62.8 | 34.5 | 2.7
| YRI | 4.8 | 30.6 | 64.6
| ASW | 12.3 | 50.9 | 36.8
| CHB | 61.3 | 38.0 | 0.7
| CHD | 58.7 | 36.7 | 4.6
| GIH | 71.3 | 25.7 | 3.0
| LWK | 8.2 | 34.5 | 57.3
| MEX | 48.3 | 44.8 | 6.9
| MKK | 7.7 | 39.7 | 52.6
| TSI | 55.9 | 35.3 | 8.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23300138
  |Trait=Tumor biomarkers
  |Title=A genome wide association study of genetic loci that influence tumour biomarkers cancer antigen 19-9, carcinoembryonic antigen and α fetoprotein and their associations with cancer risk.
  |RiskAllele=G
  |Pval=3E-22
  |OR=.07
  |ORtxt=[0.040-0.098] ng/ml increase
  }}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}